Severity of Influenza A(H1N1) Illness and Emergence of D225G Variant, 2013–14 Influenza Season, Florida, USA - Volume 21, Number 4—April 2015 - Emerging Infectious Disease journal - CDC
Volume 21, Number 4—April 2015
Severity of Influenza A(H1N1) Illness and Emergence of D225G Variant, 2013–14 Influenza Season, Florida, USA
In 2009, a novel influenza virus, influenza A(H1N1)pdm09, emerged. The resulting pandemic disproportionately affected persons <65 years of age (1), but illness caused by the virus was similar in severity to that caused by seasonal influenza (2). As the 2013–14 influenza season progressed, physicians at a Florida hospital noted that patients <65 years of age were affected in numbers similar to those seen in 2009–10, but with increased severity. To investigate these observations, we obtained the number of influenza admissions during the 2013–14 season, characterized pathologic findings in deceased patients, sequenced subtype H1N1 viruses, and assessed receptor-specific characteristics.
Dr. Iovine is the hospital epidemiologist at the University of Florida Health in Gainesville, Florida. Her research interests include the epidemiology of novel respiratory viruses and innate defense against multidrug-resistant gram-negative organisms.
We thank Gregory Gray and Gary Heil for useful discussions regarding this work.
This work was supported by the University of Florida Emerging Pathogens Institute and UF Health.
- Writing Committee of the WHO Consultation on Clinical Aspects of Pandemic (H1N1) 2009 Influenza; Bautista E, Chotpitayasunondh T, Gao Z, Harper SA, Shaw M, Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N Engl J Med. 2010;362:1708–19. DOIPubMed
- Cao B, Li XW, Mao Y, Wang J, Lu HZ, Chen YS, Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China. N Engl J Med. 2009;361:2507–17. DOIPubMed
- US Census Bureau. 2010 Census of population and housing, demographic profile summary file 1. 2010 [cited 2014 Aug 1].http://www2.census.gov/census_2010/04-Summary_File_1/Florida/fl2010.sf1.zip
- Centers for Disease Control and Prevention. People at high risk of developing flu-related complications. 2014 [cited 2014 Aug 1].http://www.cdc.gov/flu/about/disease/high_risk.htm
- Taubenberger JK, Morens DM. The pathology of influenza virus infections. Annu Rev Pathol. 2008;3:499–522. DOIPubMed
- Childs RA, Palma AS, Wharton S, Matrosovich T, Liu Y, Chai W, Receptor-binding specificity of pandemic influenza A (H1N1) 2009 virus determined by carbohydrate microarray. Nat Biotechnol. 2009;27:797–9. DOIPubMed
- Shinya K, Ebina M, Yamada S, Ono M, Kasai N, Kawaoka Y. Avian flu: influenza virus receptors in the human airway. Nature. 2006;440:435–6.DOIPubMed
- Lednicky JA, Loeb JC. Detection and isolation of airborne influenza A H3N2 virus using a Sioutas Personal Cascade Impactor Sampler. Influenza Res Treat. 2013;2013:656825. PubMed
- Lednicky JA, Wyatt DE. The art of animal cell culture for virus isolation. In: Ceccherini-Nelli L, Matteoli B, editors. Biomedical tissue culture. Zagreb (Croatia): InTech; 2012. p. 151–78.
- Glaser L, Stevens J, Zamarin D, Wilson IA, García-Sastre A, Tumpey TM, A single amino acid substitution in 1918 influenza virus hemagglutinin changes receptor binding specificity. J Virol. 2005;79:11533–6. DOIPubMed
- Zhang W, Shi Y, Qi J, Gao F, Li Q, Fan Z, Molecular basis of the receptor binding specificity switch of the hemagglutinins from both the 1918 and 2009 pandemic influenza A viruses by a D225G substitution. J Virol. 2013;87:5949–58. DOIPubMed
- Chen H, Wen X, To KK, Wang P, Tse H, Chan JF, Quasispecies of the D225G substitution in the hemagglutinin of pandemic influenza A(H1N1) 2009 virus from patients with severe disease in Hong Kong, China. J Infect Dis. 2010;201:1517–21. DOIPubMed
- Galiano M, Agapow PM, Thompson C, Platt S, Underwood A, Ellis J, Evolutionary pathways of the pandemic influenza A (H1N1) 2009 in the UK. PLoS ONE. 2011;6:e23779. DOIPubMed
- Wu C, Cheng X, Wang X, Lv X, Yang F, Liu T, Clinical and molecular characteristics of the 2009 pandemic influenza H1N1 infection with severe or fatal disease from 2009 to 2011 in Shenzhen, China. J Med Virol. 2013;85:405–12. DOIPubMed
- Ives JA, Carr JA, Mendel DB, Tai CY, Lambkin R, Kelly L, The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo. Antiviral Res. 2002;55:307–17. DOIPubMed
Suggested citation for this article: Iovine NM, Morris JG Jr, Fredenburg K, Rand K, Alnuaimat H, Lipori G, et al. Increased severity of influenza A(H1N1) virus infection during the 2013–14 influenza season, Florida, USA. Emerg Infect Dis. 2015 Apr [date cited]. http://dx.doi.org/10.3201/eid2104.141375
No hay comentarios:
Publicar un comentario